The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Galeterone in men with CRPC: Results in four distinct patient populations from the ARMOR2 study.
Robert B. Montgomery
Research Funding - Tokai
Mario A. Eisenberger
Research Funding - Tokai
Elisabeth I. Heath
Research Funding - Tokai
A. Oliver Sartor
Research Funding - Tokai
Franklin Chu
Research Funding - Tokai
Neal D. Shore
Consultant or Advisory Role - Algeta; Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium; Sanofi
Research Funding - Tokai
William Jeffery Edenfield
Research Funding - Tokai
Alan J. Koletsky
Research Funding - Tokai
David Uri Lipsitz
Research Funding - Tokai
James S. Cochran
Research Funding - Tokai
Luke T. Nordquist
Research Funding - Tokai
Jennifer Roberts
Employment or Leadership Position - Tokai
Mary-Ellen Taplin
Consultant or Advisory Role - Tokai